IML joins Hive to boost patient access to innovation
Representing 65 pharmaceutical companies, Innovative Medicines for Luxembourg (IML) joins Hive to connect with health innovators and accelerate access to new therapies for patients.
Representing 65 pharmaceutical companies, Innovative Medicines for Luxembourg (IML) joins Hive to connect with health innovators and accelerate access to new therapies for patients.